These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 5815224)

  • 21. Electroencephalographic evaluation of triclofos sodium sedation in children.
    Millichap JG
    Am J Dis Child; 1972 Oct; 124(4):526-7. PubMed ID: 4638712
    [No Abstract]   [Full Text] [Related]  

  • 22. A quantitative evaluation of the neurospasmolytic effect of orphenadrine by direct and telemedographed electromyography.
    Levine IM; Jossmann PB; DeAngelis V
    Clin Pharmacol Ther; 1967; 8(1):86-90. PubMed ID: 6016286
    [No Abstract]   [Full Text] [Related]  

  • 23. [Levamisole treatment in multiple sclerosis and spastic pyramidal syndromes].
    Truşcă E; Stoica I
    Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Neurol Psihiatr Neurochir; 1982; 27(2):125-35. PubMed ID: 6216567
    [No Abstract]   [Full Text] [Related]  

  • 24. [Influences of hypnotics (especially nitrazepam, -hydroxybutyric acid) on sleep-wakefulness mechanisms in cats].
    Takeshima T
    Seishin Shinkeigaku Zasshi; 1971 Jun; 73(6):495-532. PubMed ID: 4328480
    [No Abstract]   [Full Text] [Related]  

  • 25. Hypnotic properties of nitrazepam (Mogadon). (A comparative study of chlordiazepoxide, diazepam, nitrazepam, secobarbital and placebo in psychiatric patients).
    Bordeleau JM; Charland P; Tetreault L
    Dis Nerv Syst; 1970 May; 31(5):318-23. PubMed ID: 4913344
    [No Abstract]   [Full Text] [Related]  

  • 26. The effect of magnesium oral therapy on spasticity in a patient with multiple sclerosis.
    Rossier P; van Erven S; Wade DT
    Eur J Neurol; 2000 Nov; 7(6):741-4. PubMed ID: 11136367
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A double-blind trial with an antidepressant drug, imipramine, in multiple sclerosis.
    Dean G
    S Afr Med J; 1969 Jan; 43(4):86-7. PubMed ID: 4887642
    [No Abstract]   [Full Text] [Related]  

  • 28. A trial of oral lorazepam as premedication for digestive endoscopy.
    Bader E; Lautre G; Moshal MG; Baker LW
    S Afr Med J; 1973 Aug; 47(30):1361-4. PubMed ID: 4721496
    [No Abstract]   [Full Text] [Related]  

  • 29. Use of diazepam for the relief of spasticity in multiple sclerosis.
    Simpson CA
    Ann Phys Med; 1964; Suppl():39-40. PubMed ID: 5825182
    [No Abstract]   [Full Text] [Related]  

  • 30. [Preanesthetic oral medication in pediatric surgery: a new drug combination].
    del Nero RR; Bentivegna JE; do Amaral FD
    AMB Rev Assoc Med Bras; 1970 Nov; 16(11):403-6. PubMed ID: 5313012
    [No Abstract]   [Full Text] [Related]  

  • 31. Flurazepam: study of its hypnotic properties in normal subjects.
    Bielmann P; Pinard G; Tétreault L
    Int J Clin Pharmacol; 1972 Apr; 6(1):13-7. PubMed ID: 5048670
    [No Abstract]   [Full Text] [Related]  

  • 32. Dantrolene sodium: long-term effects in severe spasticity.
    Chyatte SB; Basmajian JV
    Arch Phys Med Rehabil; 1973 Jul; 54(7):311-5. PubMed ID: 4577936
    [No Abstract]   [Full Text] [Related]  

  • 33. [Intravenous use of nitrazepam (Mogadan) in the treatment of epilepsy].
    Martin D
    Neuropadiatrie; 1970 Aug; 2(1):27-37. PubMed ID: 5001124
    [No Abstract]   [Full Text] [Related]  

  • 34. Mogadon therapy of infantile spasms.
    Weinmann HM
    Electroencephalogr Clin Neurophysiol; 1967 Aug; 23(2):183. PubMed ID: 4166705
    [No Abstract]   [Full Text] [Related]  

  • 35. Clonazepam, baclofen and placebo in the treatment of spasticity.
    Cendrowski W; Sobczyk W
    Eur Neurol; 1977; 16(1-6):257-62. PubMed ID: 354938
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Subarachnoid application of phenol in the treatment of spasm].
    Dogan S; Jusić A
    Neuropsihijatrija; 1963; 11(3):261-8. PubMed ID: 5899911
    [No Abstract]   [Full Text] [Related]  

  • 37. [Pharmacological treatment of spasticity in multiple sclerosis].
    Heinzlef O; Monteil-Roch I
    Rev Neurol (Paris); 2012 Apr; 168 Suppl 3():S62-8. PubMed ID: 22721367
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Botulinum toxin in patients with multiple sclerosis.
    Kabus C; Hecht M; Japp G; Jost WH; Pöhlau D; Stuckrad-Barre S; Winterholler M
    J Neurol; 2006 Feb; 253 Suppl 1():I26-8. PubMed ID: 16477482
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Clinical study of sodium dantroline (Dantrium) in multiple sclerosis (author's transl)].
    Gonsette RE; Capart T; Demonty L
    Acta Neurol Belg; 1978; 78(3):141-7. PubMed ID: 352084
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Botulinum toxin (Dysport) treatment of hip adductor spasticity in multiple sclerosis: a prospective, randomised, double blind, placebo controlled, dose ranging study.
    Hyman N; Barnes M; Bhakta B; Cozens A; Bakheit M; Kreczy-Kleedorfer B; Poewe W; Wissel J; Bain P; Glickman S; Sayer A; Richardson A; Dott C
    J Neurol Neurosurg Psychiatry; 2000 Jun; 68(6):707-12. PubMed ID: 10811692
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.